E. Finn

发表

rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice

James M. Allen, J. Chamberlain, C. Murry, 2006, Nature Medicine.

Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature.

James M. Allen, D. Liggitt, J. Chamberlain, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Biodistribution and Safety Profile of Recombinant Adeno-Associated Virus Serotype 6 Vectors following Intravenous Delivery

James M. Allen, Y. Liu, J. Chamberlain, 2008, Journal of Virology.

Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction

R. Palmiter, R. Palmiter, J. Chamberlain, 2012, Gene Therapy.

Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies.

James M. Allen, S. Tapscott, C. Halbert, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Evidence for Early Local Viral Replication and Local Production of Antiviral Immunity upon Mucosal Simian-Human Immunodeficiency Virus SHIV89.6 Infection in Macaca nemestrina

Shiu-Lok Hu, Z. Ambrose, E. Finn, 2001, Journal of Virology.

Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation

J. Chamberlain, Suhail Ahmad, E. Finn, 2013, Scientific Reports.

Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells.

D. Jarvis, E. Finn, 1995, Virology.

Modifying the insect cell N-glycosylation pathway with immediate early baculovirus expression vectors

D. Jarvis, E. Finn, Donald L. Jarvis, 1996, Nature Biotechnology.

Large-scale, saturating insertional mutagenesis of the mouse genome

Hongkui Zeng, L. Madisen, Amanda J. Ebbert, 2007, Proceedings of the National Academy of Sciences.

Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy

H. Blau, W. Robinson, L. Steinman, 2018, Proceedings of the National Academy of Sciences.

Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina

P. Edlefsen, G. Barber, M. Gale, 2023, Frontiers in Virology.

Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle.

J. Chamberlain, L. Meuse, P. Gregorevic, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain.

J. Chamberlain, P. Gregorevic, E. Finn, 2007, Human molecular genetics.

Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.

J. Chamberlain, P. Gregorevic, E. Finn, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Characterization of a maternal–fetal HIV transmission model using pregnant macaques infected with HIV‐2287

E. Finn, W. Morton, D. Anderson, 2001, Journal of medical primatology.

Suppression of Maternal Virus Load With Zidovudine, Didanosine, and Indinavir Combination Therapy Prevents Mother‐to‐Fetus HIV Transmission in Macaques

R. Ho, J. Unadkat, E. Finn, 2000, Journal of acquired immune deficiency syndromes.